dendrit
cell
dc
among
first
cell
recogn
incom
virus
mucos
portal
entri
initi
interact
dc
virus
facilit
cell
activ
migrat
secondari
lymphoid
tissu
antigen
present
cell
apc
prime
specif
adapt
immun
respons
virus
howev
evolv
strategi
subvert
migratori
capac
dc
way
dissemin
infect
system
focu
role
sialic
acidbind
type
lectin
receptor
potent
upregul
type
interferon
dc
act
doubl
edg
sword
contain
viral
replic
induct
antivir
immun
also
favor
viral
spread
within
tissu
case
distant
envelop
virus
like
human
immunodefici
viru
hiv
ebola
viru
ebov
incorpor
sialic
acidcontain
gangliosid
viral
membran
effect
recogn
review
highli
induc
surfac
human
dc
upon
viral
infect
way
impact
differ
antigen
present
pathway
envelop
virus
evolv
exploit
apc
function
potent
dissemin
strategi
differ
anatom
compart
dendrit
cell
dc
potent
antigen
present
cell
apc
found
human
immun
function
key
initi
immun
invad
virus
cellular
sentinel
patrol
distinct
mucosa
upon
infect
viral
sens
trigger
rapid
innat
immun
respons
might
initi
contain
viral
spread
dc
activ
also
elicit
cellular
migrat
toward
secondari
lymphoid
tissu
dc
acquir
fulli
matur
phenotyp
becom
compet
antigen
present
activ
cell
expans
antigenspecif
adapt
cell
respons
despit
immun
activ
exert
dc
viral
infect
known
decad
virus
evolv
differ
strategi
escap
dc
antivir
activ
furthermor
certain
virus
exploit
immun
function
dc
way
colon
distant
tissu
effect
dissemin
system
discoveri
role
receptor
sialic
acidbind
iglik
express
dc
greatli
contribut
understand
virus
subvert
dc
activ
receptor
act
immunosurveil
molecul
also
effect
hijack
distinct
envelop
virus
either
infect
dc
directli
effect
transfer
bystand
target
cell
becom
product
infect
henc
function
dc
clearli
illustr
apc
trigger
antivir
immun
also
enhanc
viral
spread
via
receptor
type
transmembran
lectin
aminotermin
vset
domain
interact
sialyl
ligand
preferenti
nacetylneuramin
acid
linkag
sever
envelop
virus
includ
human
immunodefici
viru
hiv
ebola
viru
ebov
incorpor
sialyl
ligand
within
membran
integr
part
gangliosid
drag
plasma
membran
virus
bud
infect
cell
although
affin
sialyl
ligand
micromolar
rang
highavid
bind
achiev
upon
cluster
thousand
gangliosid
viral
membran
receptor
cellular
membran
moreov
contain
iglik
extracellular
domain
separ
ligandbind
site
cell
surfac
avail
interact
extern
ligand
bound
ci
cellsurfac
molecul
usual
happen
shorter
siglec
also
express
dc
vivo
role
viral
infect
mostli
studi
murin
model
focus
resid
tissu
macrophag
express
lectin
play
key
immunomodulatori
function
macrophag
locat
subcapsular
sinu
lymph
node
protect
mice
vesicular
stomat
viru
vsv
infect
contain
incom
virus
viral
sens
trigger
cytokin
releas
promot
antigen
present
b
cell
howev
studi
use
differ
retrovirus
infect
mice
shown
protect
function
macrophag
hijack
effici
viral
infect
dissemin
within
tissu
inde
robust
infect
particular
retroviru
lymphoid
tissu
spleen
requir
macrophag
pathogen
infect
retroviru
key
tip
balanc
macrophag
favor
protect
immun
function
antivir
respons
domin
replic
viru
expand
tropism
also
happen
case
amphotrop
vsv
infect
pathogen
condit
viral
captur
via
macrophag
necessari
elicit
effect
antivir
cell
respons
via
antigen
crosspresent
dc
overal
murin
studi
explain
contain
viral
replic
induc
antivir
immun
highli
pathogen
virus
also
favor
viral
spread
within
tissu
retrovirus
limit
tropism
yet
find
correl
pathogenesi
differ
human
virus
ebov
remain
larg
unexplor
caus
agent
acquir
immunodefici
syndrom
aid
pandem
affect
million
peopl
worldwid
ebov
respons
intermitt
outbreak
produc
filovirusassoci
diseas
fvd
high
fatal
rate
review
discuss
induc
human
dc
upon
viral
infect
degre
impact
differ
viral
antigen
present
rout
way
distant
envelop
virus
evolv
exploit
function
dissemin
strategi
distinct
anatom
compart
receptor
codifi
interferonstimul
gene
therefor
potent
upregul
distinct
human
dc
monocyt
macrophag
cell
sens
type
interferon
ifn
thu
infect
virus
ebov
tightli
upregul
express
apc
directli
trigger
indirectli
promot
releas
type
ifn
via
immun
activ
factor
figur
induc
secret
type
interferon
ifn
plasmacytoid
dc
pdc
tolllik
receptor
tlr
sens
upregul
dc
paracrin
manner
addit
lipopolysaccharid
lp
bacteri
transloc
upregul
dc
via
sens
autocrin
type
ifn
releas
b
ebov
infect
type
ifn
might
also
play
central
role
enhanc
express
dc
although
need
investig
pdc
may
produc
type
ifn
respons
ebov
infect
vivo
bacteri
transloc
suspect
case
gramneg
septicemia
ebovinfect
patient
parallel
viral
compon
secret
ebov
glycoprotein
may
induc
activ
myeloid
cell
signal
provid
altern
stimulu
autocrin
type
ifn
ebov
infect
solid
arrow
indic
establish
mechan
dot
arrow
suggest
process
requir
investig
ifnar
receptor
sgp
secret
glycoprotein
case
infect
level
potent
boost
acut
infect
sustainedalthough
lower
extentthroughout
chronic
stage
character
persist
immun
activ
sever
dc
type
identifi
sourc
product
cours
infect
therefor
contribut
induct
plasmacytoid
dc
pdc
consid
potent
type
ifn
produc
blood
capac
secret
respons
sens
demonstr
vitro
vivo
acut
chronic
phase
diseas
note
pdc
activ
respons
sens
induc
secret
tolllik
receptor
tlr
signal
matur
bystand
myeloid
dc
respons
potent
pdc
deriv
femal
turn
secret
cytokin
directli
upregul
express
dc
figur
addit
pdc
myeloid
dc
also
secret
type
ifn
although
releas
mostli
indirectli
trigger
immun
activ
signal
present
cours
infect
induc
express
ifnstimul
gene
dc
autocrin
manner
one
factor
bacteri
lipopolysaccharid
lp
increas
plasma
individu
due
bacteri
transloc
take
place
gutassoci
lymphoid
tissu
consequ
gut
epitheli
barrier
disrupt
occur
earli
infect
figur
lp
induc
express
dc
moreov
plasma
individu
also
stimul
express
dc
signal
via
type
ifn
receptor
explain
circul
monocyt
infect
individu
express
correl
vivo
level
plasma
viremia
level
diminish
introduct
combin
antiretrovir
treatment
moreov
type
factor
also
present
throughout
cours
ebov
infect
figur
secret
detect
human
nonhuman
primat
model
especi
lethal
case
asymptomat
ebov
infect
character
absenc
cytokin
although
vitro
pdc
expos
ebov
secret
activ
pdc
found
ebovinfect
nonhuman
primat
suggest
cell
might
produc
vivo
figur
asid
pdc
myeloid
cell
could
contribut
secret
ebov
infect
ebovlik
particl
induc
product
murin
bone
marrowderiv
dc
tlr
signal
ebov
glycoprotein
interact
human
monocytederiv
macrophag
induc
secret
cell
moreov
cleav
secret
form
ebov
glycoprotein
signal
although
secret
respons
glycoprotein
remain
unexplor
figur
noteworthi
lp
also
found
case
ebov
infect
complic
septicemia
possibl
due
bacteri
transloc
might
account
indirect
secret
ebov
infect
describ
figur
overal
presenc
type
ifn
throughout
cours
viral
infect
wellestablish
although
ebov
evolv
particular
molecular
mechan
via
viral
antagonist
protein
aid
evad
cellular
immun
sens
intriguingli
protect
role
type
ifn
respons
controversi
sinc
appar
antivir
function
earliest
stage
infect
may
turn
fuel
pathogenesi
later
stage
viral
diseas
seem
case
also
ebov
clinic
data
collect
human
outbreak
indic
elev
level
circul
well
upregul
type
ifninduc
gene
correl
fatal
diseas
outcom
thu
ebov
infect
trigger
immun
activ
state
upregul
express
dc
situat
might
favor
earli
viral
dissemin
event
otherwis
antivir
environ
viral
sens
enhanc
express
apc
facilit
infect
dc
myeloid
cell
figur
top
macrophag
although
dc
gener
resist
infect
recent
studi
show
mediat
product
infect
popul
human
dc
precursor
known
predc
even
though
dc
express
cellular
receptor
viral
coreceptor
therefor
suscept
viral
infect
vitro
infect
less
promin
activ
cell
importantli
activ
process
enhanc
express
dc
restrict
viral
infect
matur
dc
less
suscept
immatur
dc
infect
dc
also
appear
uncommon
vivo
although
report
cutan
mucos
dc
includ
vagin
epitheli
dc
yet
role
promot
infect
dc
remain
larg
unexplor
dc
subtyp
howev
restrict
factor
inhibit
revers
transcript
thu
preclud
immun
sens
synthesi
viral
antigen
bottom
convers
encod
vpx
counteract
activ
allow
revers
transcript
viral
genom
sens
via
cga
trigger
cytokin
releas
newli
synthes
protein
lead
product
viral
particl
also
proteosom
cleavag
dephosphoryl
form
host
factor
steril
alpha
motif
histidineaspart
domaincontain
protein
potent
restrict
factor
limit
infect
dc
figur
top
howev
lack
infect
actual
benefici
immun
control
remain
controversi
absenc
viral
replic
impair
viral
sens
limit
present
antigen
prime
adapt
immun
respons
contrast
natur
replic
dc
depend
counteract
viral
antagonist
vpx
figur
bottom
genom
replic
infect
dc
detect
innat
cytosol
dna
sensor
cyclic
guanosineadenosin
monophosph
synthas
cga
trigger
immun
respons
upon
dna
sens
figur
bottom
contrast
restrict
prevent
viral
dna
vdna
retrotranscript
cytoplasm
impair
induct
antivir
type
ifn
respons
figur
top
thu
viral
replic
dc
provid
addit
sourc
viral
compon
detect
via
immun
sensor
present
cell
figur
bottom
also
compromis
cell
viabil
releas
inflammatori
factor
fuel
viral
pathogenesi
previous
describ
sustain
chronic
type
ifn
respons
replic
dc
remain
hard
identifi
vivo
known
decad
dc
among
first
target
cell
encount
ebov
dc
highli
suscept
ebov
infect
complex
process
involv
sever
host
factor
whose
function
still
identifi
inde
express
activ
dc
recent
emerg
new
host
factor
implic
ebov
attach
mechan
facilit
subsequ
cytoplasm
viral
entri
figur
initi
ebov
attach
dc
surfac
mediat
sever
receptor
recogn
differ
element
viral
membran
often
redund
activ
ctype
lectin
receptor
clr
dendrit
cellspecif
intercellular
adhes
nonintegrin
dcsign
liverlymph
node
sinusoid
endotheli
ctype
lectin
lsectin
mediat
viral
attach
bind
viral
glycoprotein
receptor
timtam
famili
compris
cell
immunoglobulin
mucin
domain
receptor
along
tyroaxlm
receptor
recogn
phosphatidylserin
lipid
present
viral
envelop
figur
ebov
incorpor
sialyl
gangliosid
membran
recent
shown
virus
effect
recogn
receptor
figur
recognit
sialyl
gangliosid
ebov
modul
bind
uptak
traffick
filovir
particl
saclik
viruscontain
compart
vcc
continu
plasma
membran
figur
virus
store
compart
redirect
classic
endosom
pathway
facilit
viral
entri
cytoplasm
inde
ebov
macropinocytosi
allow
traffick
late
endosom
cleavag
viral
glycoprotein
cathepsin
b
ctsb
facilit
interact
endosom
receptor
niemannpick
trigger
cytoplasm
viral
entri
figur
thu
attach
facilit
viral
access
cell
cytoplasm
contribut
ebov
entri
dc
filovir
replic
within
cell
compromis
immun
function
prevent
adapt
immun
respons
limit
cytokin
secret
downregul
express
major
histocompat
complex
mhc
costimulatori
molecul
also
reduc
abil
dc
stimul
cell
prolifer
result
suggest
ebov
suppress
dc
function
prevent
initi
adapt
immun
respons
facilit
uncontrol
system
viru
replic
mechan
enhanc
activ
howev
clinic
data
gather
west
african
outbreak
show
strong
sustain
cell
activ
challeng
vivo
relev
viral
dcescap
mechan
overal
ebov
exploit
activ
boost
dc
infect
although
ebov
replic
promin
cell
yet
viral
infect
pose
difficult
balanc
apc
one
hand
infect
trigger
antivir
immun
via
viral
sens
antigen
present
hand
also
promot
cell
death
suppress
immun
respons
activ
particular
viral
antagonist
protein
recent
suggest
appar
paradox
overcom
divis
labor
distinct
dc
subset
therefor
dissoci
viral
infect
antigen
present
occur
distinct
dc
subpopul
mean
suscept
infect
dc
transfer
viral
antigen
resist
dc
remain
compet
launch
adapt
immun
respons
viral
infect
sever
pathway
allow
antigen
transfer
dc
secret
extracellular
vesicl
bear
particular
antigen
among
effect
one
although
function
paradigm
dc
biolog
state
particular
apc
interact
incom
virus
mucosa
would
one
process
virus
travel
lymphoid
tissu
cell
may
alway
one
present
captur
antigen
rather
pathogeninteract
dc
may
transfer
captur
antigen
apc
sever
mechan
includ
secret
extracellular
vesicl
bear
antigenload
fragment
even
alreadi
process
present
mhc
molecul
figur
top
mean
number
dc
bear
viralspecif
antigen
increas
quickli
upon
infect
thu
amplifi
initi
primari
adapt
immun
respons
importantli
induc
cell
stimul
vitro
extracellular
vesicl
requir
compet
activ
dc
deliv
costimulatori
signal
cell
figur
top
thu
antigencontain
extracellular
vesicl
overcom
need
compet
apc
activ
cell
among
distinct
cellular
receptor
express
dc
key
captur
secret
extracellular
vesicl
mechan
hijack
envelop
virus
figur
interact
extracellular
vesicl
via
recognit
sialyl
gangliosid
packag
vesicl
membran
assembl
bud
cellular
membran
virus
result
confirm
vitro
extracellular
vesicl
deriv
cell
line
primari
cell
also
murin
model
express
lymphoid
tissu
requir
trap
extracellular
vesicl
vivo
upon
captur
extracellular
vesicl
activ
dc
via
vesicl
traffick
along
receptor
toward
saclik
compart
invagin
continu
plasma
membran
allow
extracellular
vesicl
retent
figur
top
posit
compart
form
within
activ
dc
may
serv
antigen
depot
control
sustain
adapt
immun
even
sourc
antigen
directli
contact
apc
still
trigger
antigenspecif
immun
respons
antigen
could
maintain
immun
prolong
period
happen
dc
control
endosom
acidif
preserv
antigen
crosspresent
time
although
matur
activ
dc
markedli
downregul
macropinocyt
capac
cell
still
abl
captur
process
present
antigen
intern
via
endocyt
receptor
may
also
case
via
extracellular
vesicl
trap
moreov
dc
continu
captur
present
antigen
matur
vivo
could
also
initi
respons
newli
encount
antigen
cours
viral
infect
process
would
boost
express
overal
retent
distinct
virus
extracellular
vesiclecontain
compart
highlight
cell
might
act
trojan
hors
captur
filovirus
retrovirus
peripher
mucosa
carri
secondari
lymphoid
tissu
virus
effect
transmit
target
cell
contribut
system
spread
infect
recent
identifi
presenc
cell
cervic
mucosa
dc
capabl
captur
mediat
viral
transmiss
target
cell
via
transinfect
even
basal
state
appar
activ
detect
figur
inde
dc
directli
isol
human
ectocervix
display
basal
express
suffici
mediat
viral
transfer
howev
endocervix
express
lower
ectocervix
capac
enhanc
upon
stimul
figur
mostli
acquir
sexual
transmiss
cervic
mucosa
two
major
sourc
antivir
typei
ifn
respons
retrovir
infect
resid
myeloid
cell
pdc
potent
produc
soon
recruit
cervix
figur
although
increas
antivir
secret
could
limit
initi
viral
infect
could
promot
viral
captur
cervic
myeloid
cell
via
induct
well
note
cervic
fate
trap
extracellular
vesicl
dc
divers
provid
sourc
antigen
crosspresent
cell
also
stimul
antigenspecif
cell
respons
vivo
cell
stimul
take
place
either
reprocess
antigen
contain
captur
extracellular
vesicl
direct
present
previous
process
function
epitopemhc
complex
expos
vesicl
surfac
direct
extracellular
vesicl
antigen
present
absenc
lytic
degrad
within
dc
initi
describ
use
dc
popul
devoid
particular
mhcii
molecul
still
abl
activ
cell
necessari
mhcii
molecul
alreadi
present
antigen
extracellular
vesicl
trap
dc
thu
extracellular
vesicl
display
previous
process
function
epitopemhc
complex
surfac
recogn
retain
directli
transfer
dc
antigenspecif
cell
figur
top
turn
upregul
activ
dc
compet
apc
could
boost
extracellular
vesicl
uptak
magnifi
antivir
immun
respons
intriguingli
retrovirus
exploit
antigen
dissemin
pathway
usual
engag
extracellular
vesicl
reach
cell
main
cellular
target
particular
retroviru
figur
bottom
left
direct
captur
particl
vcc
ebola
viral
particl
retain
addit
compart
extracellular
vesicl
trap
activ
dc
figur
bottom
left
howev
case
recognit
viral
entri
via
lead
product
infect
dc
happen
ebov
favor
transfer
trap
virus
bystand
cell
thu
trap
virus
effici
transmit
across
infecti
synaps
suscept
lymphocyt
figur
mechan
viral
transmiss
known
transinfect
mediat
activ
monocytederiv
dc
monocyt
blood
convent
dc
predc
primari
myeloid
cell
isol
lymphoid
cervic
tissu
filovir
transinfect
dc
cell
improb
lymphocyt
larg
resist
ebov
infect
nonetheless
filovirus
display
broad
cell
tropism
infect
hepatocyt
adren
cortic
cell
endotheli
cell
among
cellular
target
thu
asid
lymphocyt
cellular
target
could
transinfect
figur
bottom
right
previous
shown
human
cell
line
bind
ebov
transinfect
hela
cell
howev
research
requir
determin
anatom
context
dc
trap
ebov
via
could
transfer
infect
suscept
cellular
target
vivo
overal
retent
distinct
virus
extracellular
vesiclecontain
compart
highlight
cell
might
act
trojan
hors
captur
filovirus
retrovirus
peripher
mucosa
carri
secondari
lymphoid
tissu
virus
effect
transmit
target
cell
contribut
system
spread
infect
recent
identifi
presenc
cell
cervic
mucosa
dc
capabl
captur
mediat
viral
transmiss
target
cell
via
transinfect
even
basal
state
appar
activ
detect
figur
inde
dc
directli
isol
human
ectocervix
display
basal
express
suffici
mediat
viral
transfer
howev
endocervix
express
lower
ectocervix
capac
enhanc
upon
stimul
figur
mostli
acquir
sexual
transmiss
cervic
mucosa
two
major
sourc
antivir
typei
ifn
respons
retrovir
infect
resid
myeloid
cell
pdc
potent
produc
soon
recruit
cervix
figur
although
increas
antivir
secret
could
limit
initi
viral
infect
could
promot
viral
captur
cervic
myeloid
cell
via
induct
well
note
cervic
biopsi
virem
patient
cell
harbor
compart
demonstr
vivo
cell
trap
virus
interestingli
similar
vcclike
structur
detect
urethr
macrophag
individu
suppress
combin
antiretrovir
therapi
implic
format
particular
structur
remain
determin
allow
transfer
virus
bystand
cell
mucosa
also
system
viral
dissemin
upon
dc
migrat
lymphoid
tissu
figur
inde
dc
bear
retrovirus
found
drain
lymph
node
distinct
anim
model
soon
h
vagin
challeng
find
origin
led
formul
trojan
hors
hypothesi
state
dc
serv
vehicl
transport
viru
entri
site
distant
tissu
propos
mechan
dissemin
femal
reproduct
tract
vaginalectocerv
mucosa
basal
dc
may
mediat
local
transinfect
target
cell
endocerv
mucosa
lower
express
boost
respons
releas
recruit
pdc
sens
dc
may
also
contribut
system
spread
due
abil
migrat
secondari
lymphoid
tissu
cell
accumul
similar
mechan
could
exploit
ebov
work
need
address
possibl
hypothes
outcom
earli
interact
dc
envelop
virus
may
key
mount
effect
antivir
respons
earli
encount
also
foster
viral
dissemin
distant
tissu
emerg
role
receptor
dc
clearli
exemplifi
immunemedi
activ
lectin
effect
hijack
unrel
virus
ebov
futur
work
address
envelop
virus
caus
relev
human
infecti
diseas
may
contain
sialyl
gangliosid
membran
recogn
alreadi
shown
henipaviru
moreov
precis
contribut
viral
immun
contain
pathogen
viral
dissemin
care
evalu
understand
mechan
may
provid
novel
avenu
combat
infecti
agent
identif
individu
natur
lack
express
due
presenc
earli
stop
codon
gene
homozygosi
indic
role
protein
essenti
may
therefor
safe
therapeut
target
develop
propos
mechan
dissemin
femal
reproduct
tract
vaginalectocerv
mucosa
basal
dc
may
mediat
local
transinfect
target
cell
endocerv
mucosa
lower
express
boost
respons
releas
recruit
pdc
sens
dc
may
also
contribut
system
spread
due
abil
migrat
secondari
lymphoid
tissu
cell
accumul
similar
mechan
could
exploit
ebov
work
need
address
possibl
sexual
transmiss
consid
major
rout
ebov
infect
howev
case
sexual
transmit
ebov
well
document
moreov
recent
mathemat
model
consist
signific
contribut
sexual
ebov
transmiss
outbreak
west
africa
importantli
infecti
viral
particl
found
semen
ebov
convalesc
individu
sever
month
follow
symptom
onset
semin
fluid
amyloid
may
enhanc
ebov
infect
cytokin
abund
semen
also
upregul
express
dc
role
receptor
assess
context
ebov
sexual
transmiss
moreov
dc
earli
sustain
target
ebov
dissemin
infect
portal
viral
entri
region
lymph
node
spleen
liver
sinc
express
ebov
replicatingtissu
receptor
could
also
boost
system
viral
spread
previous
suggest
collect
data
indic
dc
may
particip
viral
transmiss
mucosa
also
promot
system
viral
dissemin
secondari
lymphoid
tissu
hypothes
outcom
earli
interact
dc
envelop
virus
may
key
mount
effect
antivir
respons
earli
encount
also
foster
viral
dissemin
distant
tissu
emerg
role
receptor
dc
clearli
exemplifi
immunemedi
activ
lectin
effect
hijack
unrel
virus
ebov
futur
work
address
envelop
virus
caus
relev
human
infecti
diseas
may
contain
sialyl
gangliosid
membran
recogn
alreadi
shown
henipaviru
moreov
precis
contribut
viral
immun
contain
pathogen
viral
dissemin
care
evalu
understand
mechan
may
provid
novel
avenu
combat
infecti
agent
identif
individu
natur
lack
express
due
presenc
earli
stop
codon
gene
homozygosi
indic
role
protein
essenti
may
therefor
safe
therapeut
target
develop
pharmacolog
agent
block
interact
virus
could
pave
way
amelior
viral
system
dissemin
moreov
exploit
immunesurveil
function
receptor
induc
antivir
immun
respons
may
also
prove
valuabl
turn
dissect
distinct
virus
exploit
common
molecular
pathway
advanc
futur
antivir
strategi
gener
broad
spectrum
treatment
